CD274 and neoplasm: Subsequently, they demonstrated that BAMPA-O16B/siRNA lipoplex is highly effective against the simultaneous blockade of two immune inhibitory markers involved in tumor-induced immunosuppression i.e. CD47 (a cancer biomarker overexpressed and prevents tumor cells phagocytosis through interaction with myeloid inhibitory receptor SIRPa) and PD-L1.